openPR Logo
Press release

Lupus Nephritis - Pipeline Assessment, 2023 Updates | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | Equillium Bio, Hoffmann-La Roche Ltd, Genentech Inc, Genovax S.r.l.

02-28-2023 06:32 AM CET | Health & Medicine

Press release from: Global Insight Services

Lupus Nephritis

Lupus Nephritis

As per Global Insight services' assessment, about 20+ prominent pharma and biotech giants are working on 20+ drugs in the Lupus Nephritis - pipeline landscape globally. Lupus Nephritis Pipeline Insight, 2023" report by Global Insight Services provides a comprehensive analysis of the ongoing clinical development activities and growth prospect.

Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies : https://www.globalinsightservices.com/request-sample/GIS31229

Lupus Nephritis is an autoimmune kidney disease caused by systemic lupus erythematosus (SLE). It is a type of glomerulonephritis where autoantibodies affect the structures of glomeruli which results in inflammation and decreased kidney output.

Lupus Nephritis is mainly of 6 types, following minimal mesangial glomerulonephritis, mesangial proliferative glomerulonephritis, focal glomerulonephritis, diffuse proliferative nephritis, membranous glomerulonephritis and advanced sclerosing lupus nephritis.

Report Highlights

Global Insight Service's, Lupus Nephritis - Drug Pipeline Landscape, 2023 report provides an overview of the Lupus nephritis pipeline drugs. This report covers detailed insights on Lupus Nephritis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Lupus Nephritis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Key Players

• Alexion Pharmaceuticals
• Ampio Pharmaceuticals Inc
• Asahi Kasei Pharma Corporation
• AstraZeneca
• BeiGene Inc
• BioAegis Therapeutics Inc
• Boehringer Ingelheim
• Cellenkos Inc
• ChemoCentryx Inc
• Corestem Inc
• Eledon Pharmaceuticals Inc
• Equillium Bio
• Hoffmann-La Roche Ltd
• Genentech Inc
• Genovax S.r.l.
• Horizon Therapeutics plc

Buy Now : https://www.globalinsightservices.com/checkout/single_user/GIS31229

Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -

- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lupus Nephritis - Pipeline Assessment, 2023 Updates | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | Equillium Bio, Hoffmann-La Roche Ltd, Genentech Inc, Genovax S.r.l. here

News-ID: 2951440 • Views:

More Releases from Global Insight Services

Licorice Root Market to rise from $2.3 Bn (2024) to $4.5 Bn (2034) at 6.9% CAGR | Key Players: Norevo, Mafco Worldwide LLC, F&C Licorice Ltd
Licorice Root Market to rise from $2.3 Bn (2024) to $4.5 Bn (2034) at 6.9% CAGR …
Licorice Root Market Overview Licorice Root Market is gaining significant momentum worldwide, driven by the rising preference for natural, herbal, and sustainable ingredients across diverse industries. Licorice root, derived from the Glycyrrhiza glabra plant, is widely recognized for its therapeutic, flavoring, and antioxidant properties. It plays a vital role in pharmaceuticals, cosmetics, and food products. The Licorice Root Market is anticipated to expand from $2.3 billion in 2024 to $4.5 billion
IoT Security Market to grow from $22.4 Bn (2024) to $73.5 Bn (2034) at 12.6% CAGR | Key Players: Palo Alto Networks, Fortinet, Trend Micro
IoT Security Market to grow from $22.4 Bn (2024) to $73.5 Bn (2034) at 12.6% CAG …
Market Overview IoT Security Market is rapidly emerging as a crucial pillar of modern digital ecosystems, ensuring protection across connected devices and networks. With the exponential growth of Internet of Things (IoT) adoption, the risk of cyber threats has significantly increased, demanding advanced security frameworks. The IoT Security Market focuses on safeguarding data integrity, ensuring secure communication, and protecting connected systems across industries such as healthcare, automotive, smart homes, and manufacturing.
Supply Chain Security Market Expected to Grow from $4.8 Billion in 2024 to $12.3 Billion by 2034 at 9.9% CAGR | Overall Study Report
Supply Chain Security Market Expected to Grow from $4.8 Billion in 2024 to $12.3 …
The Supply Chain Security Market has become a cornerstone of global commerce as organizations increasingly recognize the need to safeguard their supply chains from disruptions, cyber threats, and operational vulnerabilities. This market encompasses an array of solutions, technologies, and services designed to protect the integrity and resilience of supply networks. From risk management and compliance tools to cargo tracking and cybersecurity solutions, the Supply Chain Security Market ensures that businesses
Vertical Turbine Pumps Market Expected to Grow from $2.9 Billion in 2024 to $5.4 Billion by 2034 at 6.4% CAGR | Overall Study Report
Vertical Turbine Pumps Market Expected to Grow from $2.9 Billion in 2024 to $5.4 …
The Vertical Turbine Pumps Market is a crucial segment of the global fluid management industry, primarily focusing on pumps designed to lift water from deep wells or reservoirs. These pumps, distinguished by their vertical configuration, ensure efficient water distribution across agricultural, municipal, and industrial applications. With growing global water demand, technological advancements, and an emphasis on sustainable water management, the market is witnessing robust expansion. Rising infrastructure development and urbanization

All 5 Releases


More Releases for Lupus

Cutaneous Lupus Erythematosus (CLE) Market
Introduction Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma. Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising
Prominent Cutaneous Lupus Erythematosus Market Trend for 2025: Advancements In C …
What combination of drivers is leading to accelerated growth in the cutaneous lupus erythematosus market? The rising prevalence of skin infections is expected to drive the growth of the cutaneous lupus erythematosus (CLE) market. Skin infections are caused by microorganisms that invade the skin, triggering immune responses that can worsen symptoms in individuals with CLE. For example, the UK saw a 33.7% increase in MRSA cases caused by skin and soft
Cutaneous Lupus Erythematosus (CLE) Market
Market Overview: The Global Cutaneous Lupus Erythematosus (CLE) Market is forecasted to achieve a High CAGR during the period 2023-2030. CLE encompasses a spectrum of dermatological symptoms that may precede or accompany systemic lupus erythematosus (SLE), an autoimmune condition impacting multiple organs. Timely diagnosis and treatment of CLE can prevent the onset of severe systemic symptoms. Market Dynamics: Drivers: Rise in Clinical Studies: Technological advancements leading to faster and accurate diagnosis have spurred additional
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth of
Lupus Erythematosus Market -API Insights, 2017
Summary Orbis Research Present “Lupus Erythematosus-API Insights, 2017” Description The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" MarketResearchReports.biz has announced the addition of a new report, titled “PharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,” to its expanding repository of research reports. The market